Who Shall Live? Who Shall Die?

Slides:



Advertisements
Similar presentations
PERSONALIZED MEDICINE: Planning for the Future You, Your Biomarkers and Your Rights.
Advertisements

Think About It You have been presented with three identical, unknown foods and told that one of them could solve the world’s hunger/nutrition problem.
Subject Selection and Assent in Pediatric Research.
MEDICAID REDESIGN – IDAHO What it would mean for Idahoans with disabilities. Presented by:
Medical Ethics Lecturer :Noha Alaggad
The principles In Medical Ethics Lecturer :Noha Alaggad
Introduction to basic principles
Health Insurance October 19, 2006 Insurance is defined as a means of protecting against risk. Risk is a state in which multiple outcomes are possible and.
Subject Selection and Recruitment David Wendler Department of Clinical Bioethics NIH, USA.
Government and Health Care Roughly 15 cents of every dollar spent in US is on health care US health care spending equaled $5841 per person in 2002 Governments.
Part I: Basic Economics Tools
Government and Health Care Roughly 15 cents of every dollar spent in US is on health care US health care spending equaled $5841 per person in 2002 Governments.
Ethics and Policy-Making in Stem Cell Research Presented by UC Berkeley’s STELA: The Science, Technology, Ethics, and Law Working Group March 22, 2007.
Economic Challenges and New Medical Technologies Laurence Baker, Ph.D. Stanford University School of Medicine
Ethical Principle of Justice principle of justice –involves giving to all persons their "rights" or "desserts" –the distribution of various resources in.
Sampling Designs and Techniques
New interventions into human ageing and social justice Dr. phil. Hans-Joerg Ehni Institute for Ethics and History of Medicine, University of Tuebingen.
 You pay a premium into an insurance pool. In the event that you are sick or injured, the insurance policy pays all or part of your medical expenses.
Health Care We must address the crushing cost of health care. This is a cost that now causes a bankruptcy in America every thirty seconds. By the end of.
CHCWG DRAFT March 2, 2006 Hearing from the American People: Preliminary Overview of Sources and Reports March 2006 Caution: Preliminary Data Do not cite.
Getting Better Value in Health Care Public Employers Health Purchasing Committee 5-23 DRAFT.
SOC Medical Futility James G. Anderson, Ph.D. Purdue University.
MEDICAL ETHICS ETHICS PROJECT. MEDICAL ETHICS MEDICAL ETHICS STUDIES PRINCIPLES OF RIGHT AND WRONG FOUR PRINCIPLES OF MEDICAL ETHICS AUTONOMY JUSTICE.
1 SCREENING. 2 Why screen? Who wants to screen? n Doctors n Labs n Hospitals n Drug companies n Public n Who doesn’t ?
Insuring America’s Health: Principles and Recommendations An Institute of Medicine Report Presented By Shoshanna Sofaer, Dr.P.H. School of Public Affairs,
Stem Cells By Sugandha Srivastav.
Research Issues Can be both sociological and ethical Excesses in the past have made rules and standards necessary Rules are participant oriented and protective.
Ethical AND legal issues in GENETICS. objective 1- introduction. 2-major needs in study of ethics. 3-Ethical Principles in Medicine. 4-The Special Position.
GENETIC TESTING WEIGHING BENEFITS AND HARMS THE ETHICAL ISSUES.
Age-Based Rationing?. Some Facts 1980, 1986: those over 65 consumed 29%, 31% (respectively) of health care expenditures Prediction: by 2040 elderly 21%
Pediatric ACOs The Characteristics of Pediatric Populations and Their Impact on ACOs.
Alyssa R. Vangeli Families USA Health Action Conference February 5, 2016 Using Medical Evidence to Design Health Insurance Benefits: Massachusetts No Copay.
Human and Animal Research 1. What issues does this raise? 2.
Copyright © 2012 Pearson Education, Inc. All rights reserved. Ethics: Theory and Practice Jacques P. Thiroux Keith W. Krasemann.
Who? What? When? Where? Why? Cecilia L. May, MD October 9, 2015.
Market Forces in Health Care Eric D. Kupferberg, PhD 23 September 2010.
Genes in Life is a place to learn about all the ways genetics is a part of your life. On this site you will learn:   How.
BIOETHICS.  Often used interchangeably but NOT the same:  Values  What’s important/worthwhile  Basis for moral codes and ethical reflections  Individuals.
McGraw-Hill/Irwin © 2005 The McGraw-Hill Companies, Inc., All Rights Reserved. Chapter 20 Government Provided Health Insurance: Medicaid, Medicare, and.
Chapter 4 Ethical Standards. Introduction Limits to what law, regulations, and accrediting standards and requirements can govern In the absence of law,
Cancer screening and cancer diagnosis. All medical advice is that the earlier you discover a cancer the greater your odds are of beating it. In part this.
24 Health Care McGraw-Hill/Irwin
Back to Basics – Approval Criteria
DILEMMAS IN HEALTH CARE
Health Care Systems and Reimbursement
Cindy Hatton President & CEO Susan Levitt V.P. Clinical Services/COO
Health Insurance.
Week 5: Ethical, Legal & Social Issues in Applied Genomics
HEALTH CARE POLICY.
Chapter 6: Social Work in Health Care
The NICE Citizens Council and the role of social value judgements
Health Care Reform in America
Value of Pharmaceuticals in Managed Care Pharmacy
Stem Cells Noadswood Science, 2016.
Consumerism and Ethical Responsibility
What Are the Differences? (Part 1)
Consumerism and Ethical Responsibility
Establishing Vaccination Policies
Social Welfare Policymaking
Ethics and Policy-Making in Stem Cell Research Presented by UC Berkeley’s STELA: The Science, Technology, Ethics, and Law Working Group March 22, 2007.
Social Welfare Policymaking
A PILOT STUDY EXAMINING CRITERIA USED TO SELECT DRUGS FOR HOSPITAL, PROVINCIAL AND NATIONAL FORMULARIES Robertson J, Newby DA, Pillay T, Walkom EJ The.
Health Care Systems and Reimbursement
Power of the people.
Differentiate between ethical and legal issues impacting health care.
11. Health and illness.
Value of Pharmaceuticals in Managed Care Pharmacy
Presentation transcript:

Who Shall Live? Who Shall Die?

Scarcity a Fact of Life We don’t want to spend all social resources on health US already spends higher percentage of its total wealth on medicine than comparable countries yet many uninsured More than a million uninsured in Michigan. Technological progress means there is more we can do but often at great cost “Three stages of medicine” Early medicine was not effective “Golden Age”—new treatments (e.g., antibiotics) saved many lives at modest cost; no question about advisability Now many procedures available but effectiveness not clear or expense is enormous. This may become an even greater issue with genetic therapies.

Macroallocation and Microallocation Macro: Distributing resources in society (world?) at large. Does everyone have a moral right to health care? What level of health care? How much of our nation’s wealth should go to medicine? Micro: Distributing resources in particular cases to particular individuals “God committee” or its present-day equivalent Eligibility for transplants HMO, Medicare, Medicaid decisions

Macroallocation and Microallocation Often the two issues merge; e.g., if certain treatments (e.g., bone marrow transplants) are not made available, no identifiable individuals will receive them. How much should we spend on different diseases (AIDS vs heart disease vs diabetes vs Alzheimer’s). This will influence microallocation too. Rescher and Childress deal with life-saving treatment, but it goes beyond this How much testing to do, sometimes testing that saves lives Recent report questioning benefits of PSA test and mammograms. “Clinical trial data suggests that 1 woman per 1,000 healthy women screened over 10 years [has life saved by a mammogram.”  Do statin drugs save lives?

Relevant moral factor? Age? Relative benefit medically Family role (children?) Past conributions Likely future contributions Responsible partly for disease because of past behavior

Rescher: The Obvious Decision is not medical but ethical Should be rationally defensible [Less obvious perhaps] As a matter of policy, simplicity, plausibility, and appearance of fairness also important Since not a technical medical question, lay people should be involved in decisions. (Also a question for ethics committees) Who has ethical expertise about policies on such things as List of qualifying treatments for Medicaid (e.g., Oregon plan) Hospital ethics committees National guidelines on stem cell research

Rescher’s Criteria: Overview Criteria for inclusion (and exclusion) Constituency Progress of science Reasonable prospect of success Criteria for comparison (Rescher: medical, family, social) Medical Relative likelihood of success Life expectancy Social Family role Potential future contribution (utilitarian) Past service to society (on grounds on equity, not utility: those who have contributed more deserve greater consideration)

One Acceptable System Five factors A=B and C=D=E and AB=CDE Rescher vs Childress One Acceptable System Five factors Relative likelihood of success Life expectancy Family role Social contributions (future expected) Social contributions (past) A=B and C=D=E and AB=CDE Medical Ethics

Larger Issue of Scarcity Allocating organs Scarce resources in a crisis: e.g., flu epidemic, bioterrorism attack Right now: Medicare/Medicaid rationing Possible overtesting, overtreatment

Rescher’s System (continued) First, inclusion criteria applied Second, comparative criteria selects a group about a third or half as large as group to be treated. Random selection of final group Recognized no system is exact or optimal Easier for those rejected to accept final outcome (Least important) Relieves administrators of heavy burden. Element of human chance supplements life’s inherent natural chance (e.g., in who gets sick enough to need life-saving treatment).

Childress: Against Social Worth Criteria Impossible to quantify human social worth: engineer vs painter? Shatin: “discover the values most people hold” Values change, there are regional differences, cannot predict future social needs MORE IMPORTANT: the whole utilitarian approach is wrong. Reduces people to social roles. “eliminates sense of person’s transcendence”

Childress: Value of Random Selection Preserves personal dignity and equality Preserves trust of physicians Rawlsian: what procedure would we choose in original position? This method can be applied to other issues too; e.g., selection for organ transplants